Avraham Gabay Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

Avraham Gabay is Chief Financial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 649,256 shares of ORMP, which is worth approximately $1.55 Million. The most recent transaction as insider was on Jan 22, 2026, when has been sold 19,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 649K

49.58% 3M change

81.34% 12M change

Total Value Held $1.55 Million

Avraham Gabay Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2026	BUY Exercise of conversion of derivative security	-	19,000 Added 2.84%	649,256 Common Stock
Dec 31 2025	BUY Grant, award, or other acquisition	-	196,216 Added 23.74%	630,256 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	76,000 Added 14.9%	434,040 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	188,000 Added 34.43%	358,040 Common Stock
Nov 07 2024	BUY Grant, award, or other acquisition	-	30,000 Added 15.0%	170,040 Common Stock
Jun 21 2024	BUY Grant, award, or other acquisition	-	140,040 Added 100.0%	0 Common Stock

Avraham Gabay

Chief Financial Officer

Jerusalem, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Value

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP

Account